Last year, we blogged about the work we did for Médecins Sans Frontiers, suggesting improvements for their Patents Oppositions Database. Need a quick recap? Two things you need to know: When medicines are re-patented, it prevents the development of generic versions. One company retains the monopoly, and costs remain high, where otherwise the generics would…

Original source – mySociety

Comments closed